Bharat Biotech’s Covaxin efficacy results in Phase III trials: REVEALED!

0 19

Bharat Biotech’s Covaxin has shown 77.8 percent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources, as per ANI.

Leave A Reply

Your email address will not be published.